Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
DNA Repair|April 28, 2017
hSSB1 phosphorylation is dynamically regulated by DNA-PK and PPP-family protein phosphatasesNicholas W Ashton, Nicolas Paquet, Sally L Shirran, et al.
Oncotarget|May 19, 2015
miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanomaMitchell S Stark, Vanessa F Bonazzi, Glen M Boyle, et al.
Cancer Research|July 19, 2005
Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cellsJian-Zhong Qin, Jeffrey Ziffra, Lawrence Stennett, et al.
Molecular and Cellular Biology|July 1, 2009
Homodimerization controls the fibroblast growth factor 9 subfamily's receptor binding and heparan sulfate-dependent diffusion in the extracellular matrixJuliya Kalinina, Sara A Byron, Helen P Makarenkova, et al.
Pigment Cell & Melanoma Research|September 21, 2010
p53 prevents progression of nevi to melanoma predominantly through cell cycle regulationTamara Terzian, Enrique C Torchia, Daisy Dai, et al.
Molecular Cancer Therapeutics|August 10, 2004
p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomasJian-Zhong Qin, Lawrence Stennett, Patricia Bacon, et al.
Gynecologic Oncology|July 15, 2014
A phase II trial of brivanib in recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group StudyMatthew A Powell, Michael W Sill, Paul J Goodfellow, et al.
Oncoimmunology|March 28, 2017
Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibitionFlorine A Eggink, Inge C Van Gool, Alexandra Leary, et al.
Biomaterials|August 11, 2019
Microenvironment engineering of osteoblastic bone metastases reveals osteomimicry of patient-derived prostate cancer xenograftsAli Shokoohmand, Jiongyu Ren, Jeremy Baldwin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2015
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiativeEllen Stelloo, Tjalling Bosse, Remi A Nout, et al.
Pageof 6